TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88383413

Filing Date: 04/12/2019

To the Commissioner for Trademarks:

MARK: OPTIZORB (Standard Characters, see mark)
The literal element of the mark consists of OPTIZORB.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, GlaxoSmithKline Consumer Healthcare (UK) IP Limited, a limited liability company legally organized under the laws of England, having an address of
      980 Great West Road
      Brentford, Middlesex TW89GS
      England
      484-885-9127(phone)
      1 215 751 7051(fax)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Analgesics; anti-inflammatory and antipyretic preparations
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of European Union Trademark - EUTM registration number 004767992, and/or proof of renewal, registered 10/11/2006 with a renewal date of 07/07/2015 and an expiration date of 12/06/2025, and translation thereof, if appropriate.

Original PDF file:
reg-15251561-070714517_._New_reg._certificate_for_OPTIZORB_EU.pdf
Converted PDF file(s) (3 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Original PDF file:
reg-15251561-070714517_._mited_to_GlaxoSmithKline_Consumer_Healthcare__UK__IP_Limited.pdf
Converted PDF file(s) (2 pages)
Foreign Registration-1
Foreign Registration-2
Original PDF file:
reg-15251561-070714517_._renewal_of_EU_OPTIZORB.pdf
Converted PDF file(s) (1 page)
Foreign Registration-1



The applicant's current Attorney Information:
      Terence A Dixon and Christopher M Hanes, Merilee J Arevalo of GlaxoSmithKline
      LBP - 3rd floor
      5 Crescent Drive
      Philadelphia, Pennsylvania 19112
      United States
      484-885-9127(phone)
      1 215 751 7051(fax)
      Trademarks@GSK.com (authorized)
The attorney docket/reference number is 82774066.

The applicant's current Correspondence Information:

Terence A Dixon

GlaxoSmithKline

LBP - 3rd floor       5 Crescent Drive

Philadelphia, Pennsylvania 19112

484-885-9127(phone)

1 215 751 7051(fax)

Trademarks@GSK.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /tad/   Date: 04/12/2019
Signatory's Name: Terence A Dixon
Signatory's Position: Trademark Counsel -member of NY and PA Bar
Payment Sale Number: 88383413
Payment Accounting Date: 04/12/2019

Serial Number: 88383413
Internet Transmission Date: Fri Apr 12 13:41:16 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-201904121341164929
35-88383413-62022f3a26354247ea3d59531bc4
c0fd25ba8d4191aef5320ea3a51f6d2814b-DA-1
6331-20190412070714517620